EXHIBIT
31.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002  I, Malcolm Skolnick,
certify that:  1. I have reviewed this Amendment No. 1 on Form 10-K/A for the year
ended December 31, 2007 of CytoGenix, Inc.;  2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;  3. Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report;  4. The registrants other certifying officers and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over
financial reporting (as defined in Exchange Act Rules 12a-15(f) and 15d-15(f)
for the registrant and have:  a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;  b) Design such internal control over financial reporting, or caused
such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statement for external
purposes in accordance with generally accepted accounting principles.  c) Evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this annual report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the
period covered by this report based on such evaluations; and  d) Disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the registrants most
recent fiscal (the registrants fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely affect, the
registrants internal control over financial reporting; and    5. The registrants other certifying officers and I have disclosed,
based on our most recent evaluation of internal controls over financial
reporting, to the registrants auditors and the audit committee of registrants
board of directors (or persons performing the equivalent function):  a) all significant deficiencies and material weaknesses in the design
or operation of internal controls which could adversely affect the registrants
ability to record, process, summarize and report financial information;  b) any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrants internal
controls over financial reporting.   Date: May 12, 2008 /s/ Malcolm Skolnick MALCOLM SKOLNICK PRESIDENT & CEO (PRINCIPAL EXECUTIVE OFFICER)